Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoely for menstrually related migraine
ACTRN12625000644460Phase 2Recruiting
- Sponsor
- Monash University
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nomegestrol acetate + estradiol in migraine, sponsored by Monash University. Primary endpoints: Composite primary outcome of safety and tolerability and Adverse events. Started May 2026; status: recruiting.
02
Drugs
nomegestrol acetate + estradiol
03
Conditions
migraine
Beyond the preview
Go deeper on ACTRN12625000644460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000644460.